Long
BXRX FDA approval lotto play
Updated
This idea comes from recent success in a Sprint trade. It was slow in coming, but it did come through very successfully, which is the impetus for this idea of "reading" tickers with binary events.
This is purely a news driven idea in which there is no technical reading of the chart what-so-ever. I have no idea if this will be correct, and am really using this platform for journaling & finding others who use similar methods. I'm getting the tickers from a freely available online calendar with the PDUFA dates.
I use a pendulum and cards I made up to gain information on the "energy" of the situation. Anyone doing anything similar, please contact me to share information. I'm definitely on the fringes here.
BXRX has a deadline for an FDA approval tomorrow (2/20/20).
My indications are that it is APPROVED. I don't read about the details of the application and I don't care, although reading it may help my insomnia ;)
BXRX is currently trading at the LOD $7.88 - 5.97%
Indications are it could go up to $9.14
The ATH is $9.60
We shall see...
This is purely a news driven idea in which there is no technical reading of the chart what-so-ever. I have no idea if this will be correct, and am really using this platform for journaling & finding others who use similar methods. I'm getting the tickers from a freely available online calendar with the PDUFA dates.
I use a pendulum and cards I made up to gain information on the "energy" of the situation. Anyone doing anything similar, please contact me to share information. I'm definitely on the fringes here.
BXRX has a deadline for an FDA approval tomorrow (2/20/20).
My indications are that it is APPROVED. I don't read about the details of the application and I don't care, although reading it may help my insomnia ;)
BXRX is currently trading at the LOD $7.88 - 5.97%
Indications are it could go up to $9.14
The ATH is $9.60
We shall see...
Note
And why I didn't do a new reading after it hit the target, IDK?! Wish I had shorted that's for sure.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.